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ABSTRACT 
          MftC is a radical S-adenosyl L-methionine (SAM) enzyme that catalyzes the first 
step in the production of mycofactocin. It is a ribosomally synthesized post-translationally 
modified (RiPP) redox cofactor shown to be essential for the survival of bacteria in the 
Mycobacterium genus in the presence of cholesterol as a carbon source and for the 
sequestration of ethanol. MftC catalyzes the C – terminal decarboxylation of tyrosine and 
the subsequent cross-linking of tyrosine to the penultimate valine on the precursor peptide 
MftA. The product formed out of the reaction is processed into mycofactocin in 
downstream processes. The bacteria in the Mycobacterium tuberculosis complex are 
pathogens that primarily affect mammalian lung systems and are subjected to oxygenated 
environments. It is also known that the bacteria in Mycobacterium species require highly 
aerobic conditions to survive. Radical SAM proteins require anaerobic conditions to 
catalyze reactions as their [4Fe-4S]2+ clusters are vulnerable to degradation by oxidation. 
MftC has to function when Mycobacterium species is present in oxygen rich environments 
such as lung tissue. Discerning the mechanism by which such an enzyme works in oxygen 
rich environments could provide insights into radical SAM chemistry. In order to 
investigate the effect of aerobic condition on the MftC reaction, here we seek to measure 
and demonstrate the change in efficacy of the MftC reaction after varying levels of oxygen 
exposure. We show that while the rate of the first part of the MftC reaction is slowed on 
exposure to oxygen, the second part of the reaction – the C – C cross-linking remains 
relatively unaffected on oxygen exposure.  
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CHAPTER ONE: INTRODUCTION 
 
Ribosomally synthesized and post-translationally modified peptides (RiPPs) 
 
Natural products can be defined as molecules or substances derived from natural 
sources and that which are produced biosynthetically [1].Natural products have been an 
intrinsic part of nature almost since the beginning of life and have been a major source of 
bioactive compounds [2] which play major roles in nearly all life processes [3]. Natural 
products have also played a fundamental role in changing our way of life [4] and  have 
been a source of lifesaving antibiotics throughout history [5]. Examples include the 
discovery of aspirin in its earliest forms and penicillin [6] to modern therapeutic agents for 
congestive heart failure and hypertension [7]. Natural products have also been useful in 
providing inspiration for the development of new materials and photovoltaic cells [8].  
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a 
class of natural products which have gained considerable significance in the last decade. 
They differ from non-ribosomally synthesized natural products which require extensive 
enzymatic complexes for their biosynthesis [9]. Instead, RiPPs are generally 
biosynthesized by the addition of post-translational modifications (Figure 1) on a core, 
ribosomally synthesized  peptide [10] which enables them to considerably increase their 
functional repertoire, often rivaling the non-ribosomally produced natural products in their 
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structural and chemical diversity [11]. Initially, the ribosomally synthesized and post-
translationally modified peptides were classified according to the either their biological  
              
activities [12] or the organisms they had originated from [13]. The classification system 
was redefined and the acronym ‘RiPPs’ decided upon for ‘Ribosomally synthesized Post-
translationally modified Peptides’ after a consensus was reached by leading researchers in 
the field on classifying them based on the type and functionality of Post-translational 
Modifications (PTM) [10]. A size restriction of 10 kDa was also imposed on the 
classification system for the precursor peptides which undergo the PTM’s to exclude post-
translationally modified proteins [10]. 
The shift of methods for identifying potential natural products from traditional 
methods of targeted genera selection [14], exploration of organisms found in new ecologies 












RiPP gene cluster 
Figure 1. Illustrative schematic of a typical RiPP pathway.  The precursor peptide 
is expressed with an N – terminal region and a C – terminal core which are cleaved 
off and processed into the final product. 
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[16] to genome mining methods [17] have revolutionized both the quality and quantity of 
RiPPs pathway discoveries. 
Following the development of the classification system [10], RiPPs have been 
classified into subfamilies based on the structural features and functionalities that their 
biosynthetic pathways confer on them. A brief review of prominent members of the RiPP 
family, their functions and origins – including mycofactocin are discussed below to add 




The term ‘Lanthipeptide’ is an abbreviation which stands for ‘Lanthionine-
containing-peptides’ [10]. The defining PTM of this class results in lanthionine (Lan) and 
3- methyllanthionine (Melan) residues which are formed by two alanine residues 
crosslinked through a thioether linkage of their β-carbons and an additional methyl group 
in the linkage respectively [18]. Lanthipeptides were some of the earliest natural products 
to be identified to have a ribosomal origin [19]. The final Lan and MeLan residues are 
introduced as PTMs through a two-step process involving a dehydration step and a 
Michael-type addition [20][21] with the steps usually also involving the formation of a 
phosphorylated intermediate [22] between the two steps. The cross link generating 
enzymes usually require the presence of a leader peptide [23] [24] although exceptions to 
this norm exist [25]. Lanthipeptides have traditionally known to antibiotics as many them 
are lantibiotics (lanthipeptides functioning as antibiotics) [26]. Emerging research has 
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Proteusins are cytotoxic polytheonamides first reported in 1994 [31]. They feature 
many D-amino acids in alternation with L-amino acids and feature an unusual lipophilic 
N-acyl unit [32]. The cytotoxicity of these polytheonamides has its basis in part due to their 
ability to form membrane channels [32]. The biosynthesis of a typical proteusin molecule 
begins with the expression of the precursor peptide molecule (PoyA) which undergoes a 
unidirectional epimerization of specific L – amino acids in the first step [33]. This is 
followed by the formation of a unique N-acyl residue by the dehydration of a Thr residue 
[34] [35]which is again followed by the cleavage of the leader sequence by hydrolysis. The 
post translational modifications happens on 18 residues in the precursor peptide and all the 
posttranslational modifications including the formation of the unique N-acyl residue 
Figure 2. Lacticin 3147 α, a representative member of the Lanthipeptide family of RiPP 
molecules. The PTMS (crosslinks) originating from Cys residues are marked in blue 
whereas the PTMs (segments) originating from Ser/Ther residues are shown in red.  
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constitute a total of 48 modifications in total which makes Proteusins some of the most 
post translationally modified RiPP molecules [34].  
              
  
Linear azol(in)e-containing peptides (LAPs)  
 
LAP’s were discovered to have RiPP like properties in the year 2000 [36]. They 
play a significant part in the pathogenesis of Streptococcus pyogenes and other strains of 
various bacteria [37]. The PTMs that characterize this subfamily are azol(in)e rings on the 
precursor peptide [38]. The biosynthesis of this class of RiPPs begins with the recognition 
of the precursor peptide and the formation of the enzyme substrate complex which then 
proceeds on to an ATP dependent cyclodehydration step where a water molecule is 
expelled from an amide carbonyl forming an azoline heterocycle [39]. The second step in 
the biosynthesis proceeds with an FMN-dependent dehydrogenase oxidizing all or some of 
the azolines to azoles which is generally followed by cleavage of the leader peptide from 
the core precursor peptide [38] [40].  
Figure 3. Polytheonamide B – a proteusin is shown here with PTMs are color 
coded. Epimerization modifications are shown in green, methylation in blue, 
dehydration in red and hydroxylation in purple. 
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Cyanobactins are cytotoxic peptide products found predominantly in marine 
organisms like the ascidians and cyanobacteria [41]. The first examples of these RiPPs 
were isolated from Lissoclinum patella [42] and unlike Proteusins, these RiPPs are small, 
ranging between 6 – 20 amino acids in length with about 200 different cyanobactins 
identified so far [43]. The biosynthesis of Cyanobactins begins with the usual expression 
of the precursor peptide containing the leader or recognition sequence, the core sequence 
and the C – terminal sequence. The Cys, Ser and Thr residues are modified into oxazoline 
and thiazoline as a first step in the production of the cyanobactins. The N terminal 
recognition sequence as well as the C terminal sequence are cleaved off to prepare the core 
peptide for C-N macrocyclization [44]. Some further processing is found in specific 
instances where incorporation of isoprenoids can occur [45]. Cyanobactins while being 
cytotoxic, have been known for their transition metal binding properties [46], they have 
been found to be selectively toxic to certain human cancer cell lines [47] and are also 
known to act as a blocking agent towards P-glycoprotein [48]. 
Figure 4. Plantazolicin – a member of LAPs. PTMs are color coded. Thiazoles derived 
from Cys residues are shown in green while the methyloxazoles derived from Ser/Thr 
residues are shown in purple. 
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Thiopeptides are a class of RiPPs whose defining features are the presence of 
piperidines, dehydropiperidines and pyridines [49]. The biosynthesis of thiopeptides 
begins with expression of the precursor peptide which undergoes a series of modifications 
which include the dehydration of Ser and Thr residues to produce Dha and Dhb 
residues[50] followed by the cyclization of the linear peptide [51]. Thiopeptides are mostly 
known for their antibacterial properties through impedance of protein synthesis [52]. 
Certain thiopeptides are also known to exhibit anti-cancer and anti-malarial activity 
through the induction of apoptosis [53], [54]. 
 
                      
Figure 5. A. Microcyclamide and B. Trunkamide are representative examples of 
Cyanobactins. The PTMs in Microcyclamide are the heterocyclizations of Cysteine 
residues which are shown in green and the heterocyclization of a Serine residue showin in 
purple. The PTMs in Trunkamide are the heterocyclization of cysteine shown in green and 








Bottromycins are RiPPs that contain C – methylated amino acids, decarboxylated 
C – terminal thiazole and macrocyclic amidines [55]. The biosynthesis of Bottromycins 
follows a unique process where the precursor peptide does not have a defined N – terminal 
recognition sequence but has an extended C – terminal sequence whose function has not 
been established [56], while the order of the posttranslational modifications is currently 
unknown, their antimicrobial activity against drug resistant Staphylococci has been well 
documented [57]. 
 
           
Figure 6. Micrococcin, a representative thiopeptide structure. The thiazole and 









Lasso peptides are RiPPs primarily produced by actinobacteria and proteobacteria 
and are of 16 to 21 amino acid residues in size [60], [61]. The Lasso peptides are named 
after a characteristic fold present in the final product which confers resistance to proteases 
and other means of denaturation [62], [63]. The Biosynthesis of lasso peptides occurs 
through acquisition of the characteristic lasso fold from the precursor peptide and the 
cleavage of the leader peptide through an ATP dependent process [64], [65]. Lasso peptides 
are employed as anti-bacterial agents by the producing bacteria to outcompete 
phylogenetically similar bacteria in colonizing biotopes [66]–[68].  
 







Figure 7. Bottromycin A2 – an example of Bottromycin structures. 
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Microcins are generally plasmid encoded small, antimicrobial RiPPs usually 
smaller than 10 kDa in size and are produced by Enterobacteria [58]. Microcins are 
presently classified into two classes – class I which is composed of microcins below 5kDa 
in size while class II consists of microcins which are from 5 to 10 kDa in size [59]. Most 
microcins are produced in a traditional manner that is typical of RiPP biosynthesis where 
a precursor peptide is expressed with an N – terminal leader domain and a C – terminal 




core which undergo post-translational modifications, resulting in the formation of mature 
microcin peptide [58]. 
 





Microviridins are RiPPs produced by freshwater cyanobacteria[69], [70] which are 
primarily produced involved in protease inhibition of elastase[71], subtilisin[72] and 
trypsin [73]. The Microviridin family consists of N – acetylated peptides that contain 
Lactams and lactones after undergoing post translational modifications with ω-amide and 
ω-ester bonds [69], [74].  
Figure 9. General PTM of a class IIb microcin shown in blue. A linear trimer of 2,3-
dihydroxybenzoyl L-serine is linked via a C-glycosidic linkage to a b-D-glucose. The 
glucose is anchored to the carboxylate of the C-terminal serine residues of the peptides 











Sactipeptides are RiPP molecules which are characterized by the presence of post 
translational modifications in the form of intramolecular bonds between cysteine sulfurs 
and the α-carbon of a different residue [75]. The first member of this family – Subtilosin 
A was discovered in 1985[76] and  structurally characterized in 2003 [77]. Subtilosin A 
Figure 10. Microviridin B from M. aeruginosa. The Post-translationally 
modified ω-ester and ω-amide bonds are shown in blue and red respectively.  
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has been reported to have spermicidal and antimicrobial activity over a narrow range of 
bacteria [78]–[80]. The Biosynthesis of sactipeptides is thought to proceed in a fairly 
typical manner with the expression of the precursor peptide and the formation of thioether 
bond formation as the first step as demonstrated in the case of Subtilosin A [81]. The N-
terminal leader peptide is then thought to be cleaved off of the C – terminal core followed 
by a cyclization step as the final step in the production of Subtilosin A [82]. 
           
 
RiPP redox cofactors and other small RiPP molecules  
 
An increasing number of small molecules are being discovered which are produced 
through RiPP biosynthesis, prominent examples of which are pyroloquinone quinone 
(PQQ), mycofactocin (MFT) and pantocin A [83]–[85]. PQQ is a known redox cofactor 
used in substrate oxidation which is utilized in the production of cellular ATP via a non-
glycolytic pathway in a wide variety of bacterial genera [86] while MFT is a putative redox 
cofactor shown to be essential for the utilization of cholesterol for metabolism and 
assimilation of ethanol [87][88]. Pantocin A is a peptide derived antibiotic known to be 
effective against plant pathogens [85]. All three of the mentioned RiPP products start with 
Figure 11. Subtilosin A, one of the defining members of the sactipeptide family. The 
residues involved post-translationally modified D-configured thioether bonds are 
shown in blue while the residues involved in L-configured bonds are shown in red.  
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a precursor peptide which is processed further resulting in the final finished RiPP molecule. 
The downstream processing of MFT is elaborated in the following segments.  
 
 













Figure 12. Structures of A. PQQ (Pyrroloquinoline quinone) B. Pantocin A and C. Putative 
structure of MFT (Mycofactocin) 
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Radical SAM enzymes in RiPP Biosynthesis 
 
Radical S-adenosyl methionine (rSAM) enzymes are characterized by the presence 
of a conserved Cx3Cx2C motif which coordinates a redox active [4Fe-4S]
2+ cluster and 
were categorized as a superfamily early in 2001 [89]. They are ubiquitous and are present 
in all phylogenetic kingdoms of life. The enzymes of this superfamily tend to generally 
adopt a partial triose-phosphate isomerase fold or (TIM) barrel fold (β/α)6 whose C or N 
terminals can have different customized extensions for specific reactions or structures [10]. 
An example of a rSAM enzyme is shown in Figure 13 which depicts the structure of the 
Anaerobic sulfatase maturating enzyme (anSME), a homolog to MftC, the radical SAM 
protein employed by the mycofactocin pathway, determined by X – ray crystallography 
(PDB ID: 4K36).  
                   
Figure 13.  Crystallographic structure of anSME, an rSAM enzyme (PDB 
ID 4K36) shown in ribbon format. The SAM cluster hosting Triose-
phosphate isomerase (TIM) barrel is shown in green while the SPASM 
domain is shown in purple which hosts both the auxiliary [4Fe-4S] clusters. 
16 
 
The characteristic Cx3Cx2C motif binds three out of the four iron atoms in the [4Fe- 
4S]2+ cluster and the fourth iron is labile and is referred to as the unique iron. The unique 
iron of the SAM cluster is coordinated by the amino and carboxylate moieties of S-
adenosyl methionine (SAM) (Figure 14) and this complex forms the defining part of the 
whole catalytic machinery of rSAM enzymes [90]. 
                     
Radical S-adenosyl methionine enzymes facilitate a homolytic reductive cleavage 
of SAM which generates a methionine and a 5’deoxyadenosine radical (Figure 15) [91]. 
The highly reactive 5’deoxyadenosine radical in turn abstracts a hydrogen atom from the 
substrate molecule in a regionally specific and a stereospecific manner [92]. This 
mechanism is employed by MftC. The substrate radical which is typically formed on 
Figure 14. The conserved Cysteine motif which co-ordinates the SAM cluster 
in anSME (PDB ID 4K36) shown with the SAM molecule coordinating the 






precursor peptide usually undergoes further modifications by downstream enzymes before 
becoming the final product.  
             
There are several RiPP pathways which employ rSAM enzymes as important steps 
in RiPP maturation and production [93]. Different RiPP pathways employ rSAM enzymes 
for different ends with varied functionalities [94] and can be loosely grouped into 
categories based on the type of reactions and Post – translational Modification (PTMs) that 
they catalyze [95]. Based on all the rSAM enzymes characterized so far, they are broadly 
grouped into enzymes that catalyze C – methylation[96], thioether bond formation[75], 
epimerization[97], rearrangement, C – C bond formation[98] and decarboxylation[95]. 
C – methylation reactions catalyzed by rSAM enzymes proceed through the 
methylation of nucleophilic (e.g.) and non-nucleophilic (e.g.) positions in the precursor 
peptides in the process of the production of a RiPP molecule [35], [99]–[101]. Radical S-
adenosyl methionine enzymes that catalyze C – methylation reactions have been grouped 
Figure 15. Reductive cleavage of S-Adenosyl Methionine (SAM) by the rSAM cluster 
resulting in a 5’-deAdo● radical 
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subclasses which include class A which utilize active site cysteines for the methylation 
reactions, class B includes enzymes with an N – terminal cobalamin binding domain, 
enzymes in Class C employ two SAM molecules to perform methyl transfer and Class D 
enzymes are characterized by the use of methylenetetrahydrofolate as methyl donors in the 
methyl transfer reactions [102]. Examples of RiPP pathways that employ C – Methylation 
reaction catalyzing rSAM enzymes are the Thiostrepton biosynthesis pathway 
[103][104][105], Polytheonamide biosynthesis [34][106][107], Nosiheptide biosynthesis 
[108][109][110] and Thiomuracin biosynthesis [111][112][113]. 
               
Thioether bond formation reactions in RiPP biosynthesis involve the formation of 
bonds between the sulfur atom in Cys residues to either α – carbon of an acceptor amino 
acid [114] or the β – carbon of Ser/Thr residues [115]. Examples of pathways where rSAM 
enzymes are used for catalyzing thioether bond formation include Subtilosin A 
biosynthesis[116], Sporulation killing factor biosynthesis[117], Thurincin H biosynthesis 
[118][119]and SCIFF peptide biosynthesis[120][121]. 
 
 
Figure 16. TsrM, a cobalamin binding rSAM enzyme catalyzes the first step in the 
Biosynthesis of Thiostrepton where the indole ring of L-Tryptophan is methylated at 
the C2 position on the precursor peptide TsrA. The modification is shown in red.  
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Epimerization reactions, as the name implies involves the catalyzation of 
introduction of D-amino acids into RiPP molecules by rSAM molecules. The most 
prominent examples of rSAM molecules that facilitate these reactions are PoyD from the 
Proteusin biosynthesis pathway [34][107], YydG from the Epipeptide biosynthesis 
pathway [122]. 
               
 
Figure 17. Reaction catalyzed by AlbA, an rSAM enzyme harboring three [4Fe-
4S] clusters which is catalyzes the thioether bond formation between thiol groups 
of Cys residues and α- carbon atoms on the precursor peptide SboA as the first 
step in the biosynthesis of subtilosin A. 
Figure 18. Reaction catalyzed by YydG, a two [4Fe-4S] cluster containing rSAM 
enzyme that catalyzes the epimerization of Val36 and Ile44 on the precursor peptide 
YydF in the RiPP epipeptide biosynthesis pathway. 
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Rearrangement reactions are characterized by extensive rearrangements catalyzed by 
rSAM enzymes upon substrate radicals as the name suggests. One of the most important 
examples of rSAM enzymes  of this category are again Nosiheptides [123].      
                      
C – C crosslinking modifications are post-translational modifications where peptide 
crosslinks are catalyzed by the rSAM enzyme encoded in the RiPP pathway. The most 
common examples of pathways involving rSAM enzymes that catalyze peptide crosslinks 
are the Streptide biosynthesis[124][125] and the Pyrroloquinoline quinone (PQQ) 
biosynthesis pathways[83][126]. The PQQ pathway is also more extensively discussed in 






Figure 19. Reaction catalyzed by NosL, the second rSAM enzyme in the 
RiPP nosiheptide biosynthetic pathway which catalyzes the 
transformation of L – tryptophan into 3 – methyl – 2 indolic acid along 
with byproducts. 
Figure 20. Reaction catalyzed by StrB, a two [4Fe-4S] cluster carrying rSAM enzyme 




C – C crosslinking and Decarboxylation reactions are found to be catalyzed together in 
single pathway in only one RiPP pathway so far – the Mycofactocin pathway [84] which 
is discussed in detail in the next sections. 
 
SPASM subfamily of radial SAM enzymes 
 
              The SPASM subfamily of rSAM enzymes was named after the RiPP pathways 
which produce Subtilosin A, Pyrroloquinoline quinone, Anaerobic sulfatase, and 
Mycofactocin which involve the rSAM enzymes AlbA, PqqE, anSME and MftC 
respectively in their pathways [127]. These rSAM enzymes share a C terminal domain 
which has a CX9–15 GX4C-gap-CX2CX5CX3C-gap-C (seven cysteine) motif [128] which 
coordinates two other [4Fe-4S]2+ clusters which termed as Auxilliary cluster I (Aux I) and 
Auxilliary cluster II (Aux II) and they are involved in the modification of the precursor 
peptide of the pathway [129] [128] [130]. 
              An example of a rSAM enzyme in the SPASM family is anSME from Clostridium 
perfringens. AnSME facilitates the catalyzation of post-translational modification of 
arylsulfatase active site residues of either cysteine or serine into catalytically important 
formylglycine moiety [53]. This sulfatase activity is found to be important for both humans 
and anaerobic bacteria with malfunction or lack of enzymatic activity resulting in disease 
in humans [131].  The molecular structure of AnSME has been determined through X-ray 
crystallography up to a resolution of 1.8 Å (Figure15) [132]. The N terminal portion of the 
protein shows a partial triose-phosphate isomerase fold (β/α)6 (TIM) barrel fold which 
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spans from residue 3 to 324 and this domain is termed as the AdoMet domain as it contains 
the rSAM cluster coordinated by a CX3CXФC motif (C15, C19 and C22). In addition to 
the core TIM barrel, there is also a C terminal extension which shows two auxiliary [4Fe-
4S]2+ clusters coordinated by the seven cysteine motif in which the Aux I cluster is 
coordinated by C255, C261 and C276 and the Aux II cluster is coordinated by C317, C320 
and C326 from the second part of the seven cysteine motif (Figure 10). Hence the iron-
sulfur clusters are spread in such a way that the ‘SAM cluster’ is situated near the N 
terminus, the Aux I cluster is situated near the middle of the protein sequence and the Aux 
II cluster is situated near the C terminus of the protein. The distances between the SAM 
cluster and the Aux I cluster is 16.9 Å, the distance between the Aux I cluster and the Aux 
II cluster being 12.9 Å and the distance between AuxII cluster and the SAM cluster comes 
to 26.AlbA and SkfB are two rSAM enzymes involved in the biosynthesis of sactipeptides 
subtilosin A and sporulation killing factor respectively [81] [133]. AlbA belongs to the 
SPASM subfamily of rSAM enzymes as it contains two auxiliary iron-sulfur 









Figure 21. SPASM domain of anSME (PDB ID 4K36) shown in purple and in ribbon format. 
The domain holds both the auxiliary clusters – Aux I and Aux II shown as stick 
representations and being coordinated by conserved cysteine motifs.  
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clusters whereas SkfB has only one auxiliary cluster which makes it a member of another 
subfamily of rSAM enzymes known as the TWITCH whose members contain only one 
iron-sulfur cluster in their C terminal extensions. AlbA catalyzes the formation of thioether 
bonds between sulfur atoms of three cysteine residues and the α-carbons of two 
phenylalanines and one threonine. This reaction forms an essential part of the subtilosin A 
biosynthesis and maturation [134]. Sactipeptides, as mentioned previously, are produced 
by soil bacteria such as Bacillus subtilis which have been known to show antibacterial 
activity against pathogens, gram-negative and gram-positive bacteria [80]. 
PqqE is an rSAM enzyme in the PQQ biosynthesis pathway, it is a founding 
member of the SPASM subfamily of rSAM enzymes and is an essential part of the PQQ 
biosynthesis pathway. PQQ, as mentioned previously, is a redox cofactor involved in an 
alternate non glycolytic pathway in the production of ATP [86]. It is produced in a wide 










The mycofactocin biosynthetic pathway and MftC 
Mycofactocin (MFT) is a putative redox cofactor whose biosynthesis is encoded by 
the mftABCDEF gene cluster (Figure 22). These genes occur in all-or-none fashion in 
nearly six hundred species of bacteria and especially concentrated in the Mycobacterium 
genera[136], [137]. Mycofactocin was also recently shown to be important for ethanol 
assimilation and redox metabolism in Mycobacterium smegmatis [88]. 
       
MftA is a ribosomally synthesized precursor peptide that contains a highly 
conserved C-terminal IDGXCGVY sequence. MftB is a small peptide chaperone with 
predicted homology to the RiPP recognition element (RRE) PqqD in the PQQ biosynthesis 
pathway [138]. MftC is a rSAM protein belonging to the SPASM subfamily which is also 
one of its founding members. The enzyme catalyzes the oxidative decarboxylation and 
carbon – carbon bond formation in the precursor peptide MftA [138], which comprises the 
first step in the biosynthesis of mycofactocin. MftE is a peptidase [139] that cleaves the 
leader peptide off the precursor peptide and MftD is an FMN dependent oxidative 
deaminase [140] which installs the redox center on mycofactocin.  
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MftC, as mentioned earlier, is a rSAM enzyme catalyzing the SAM dependent 
oxidative decarboxylation of the C-terminal tyrosine on the precursor peptide MftA. This 
reaction is followed by another SAM dependent reaction which results in a C – C bond 
formation between Cβ of the penultimate valine and Cα of the C terminal tyrosine forming 
a 3-amino-5-[(p-hydroxyphenyl) methyl]-4,4-dimethyl-2-pyrrolidinone moiety or AHDP, 
hereafter referred to as MftA*.   
MftC has been confirmed to have three [4Fe-4S]2+ clusters as other members in the 
SPASM subfamily [141] and it has been shown that while the auxiliary clusters are not 
needed for SAM turnover, they are required for the coupled reaction for the modification 
of the precursor peptide. It should also be noted that while all other members of rSAM 




family of proteins catalyze net oxidative reactions on the peptide substrate, MftC is unique 
in that it accommodates both oxidative and redox neutral reactions while modifying the 
precursor peptide MftA [141]. A brief schema of the reaction mechanism is shown below: 
              
Typically, [4Fe-4S]2+ clusters are oxygen sensitive and can quickly degrade in the 
presence of oxygen in the solvent or when exposed to air[142].  Many rSAM proteins are 
usually found to have [3Fe-4S]+ clusters in as-isolated state or when exposed to air [143]. 
Although reductants like dithiothreitol help with scavenging iron out of the solvent to 
reform the [4Fe-4S]2+ cluster, it is still difficult to initiate reactions in an oxygenated 
environment. 
M. tuberculosis infects a highly oxygen rich environment[144][145] and under 
hypoxic conditions enters stationary phase growth[146]. The effect of oxygen on [4Fe-4S] 
clusters calls into question the tolerance that MftC has towards oxygen. Investigating the 
effect of oxygen on rate of degradation of clusters in MftC and the subsequent effect on 
the rate of the peptide modification has potential to shed light on its in vivo mechanism of 
Figure 24. Major steps of the MftC reaction where MftA is converted into MftA* 
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action in the M.tuberculosis bacterium when it infects a highly oxygen rich environment 
as the tissue of the alveolar air sacs [147].  Investigating aerobic degradation of the iron 
sulfur clusters in MftC can also give further insights into the function of the SPASM family 
of rSAM proteins and lay foundations for predicting new SPASM like rSAM proteins 


























CHAPTER TWO:MATERIALS AND METHODS 
 
Expression and purification of MftC: 
 
The MftC gene (Uniprot: A0PM49) was co-transformed in the BL21 Star(DE3) cell 
line with suf operon plasmid pPH151. An overnight culture from the transformed cells was 
used to inoculate 4 L of TB (Terrific Broth) medium. The cells were grown at 215 RPM 
and 37℃ till an OD600 measurement of 0.7 to 0.8. The culture was then cooled to a 
temperature of ~21℃ and protein production was induced by adding 1mM IPTG 
(Isopropyl β-d-1-thiogalactopyranoside), 50µM of FeCl3 (iron (III) chloride) and 0.75g/L 
Na2C4H2O4 (sodium fumarate). The cells were then incubated overnight at 21℃ for 16 – 
18 hours.  Cells were harvested by centrifugation at 6500 g for 10 min and the cell pellets 
were flash frozen and stored at −80℃ for further use. 
The frozen cell pellets were thawed inside an anaerobic chamber and suspended in 
5 times the cell pellet weight of lysis buffer (50 mM HEPES, 300 mM NaCl and 40 mM 
Imidazole). Lysozyme (0.5% w/v), CHAPS (0.75% w/v) and DNAse (Bovine Pancreas, 
0.05mg/g of thawed cells) were added and the suspension was stirred for 25 min at room 
temperature inside the anaerobic chamber. The cell suspension was sealed in centrifuge 
tubes, removed from the chamber, centrifuged at 13000 g for 10 min, and transferred back 
into the anaerobic chamber where an ÄKTA Start FPLC system was used to load the 
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supernatant onto two Ni2+His-trap columns (GE Life Sciences). The columns were washed 
with 5 column volumes of lysis buffer (50 mM HEPES, 300 mM NaCl and 40 mM 
Imidazole) to wash out nonspecifically bound protein matter and other cell debris. The 
columns were then washed with elution buffer (50 mM HEPES, 300 mM NaCl and 300 
mM Imidazole), the UV absorbance of the eluate was monitored, and appropriate fractions 
were collected, pooled and buffer exchanged into storage buffer (50 mM HEPES, 300 mM 
KCl, 10 mM DTT and 10% v/v Glycerol).  
 
Reconstitution of MftC: 
 
Reconstitution of the purified MftC fractions were carried out entirely inside the 
anaerobic chamber immediately after purification. All reagents used in the reconstitution 
procedure were taken into the chamber in powder form and dissolved in deoxygenated DI 
water. DTT (10 mM) was added to the purified protein and the solution was stirred at 4℃ 
for 10 min followed by the addition of 12-fold protein concentration of FeCl3 and stirred 
again for 10 min at 4℃. This followed by an addition of 12-fold protein concentration of 
Na2S and the solution was incubated at 4℃ while being stirred gently for 45 min. The 
solution was then centrifuged at 14000 g for 5 min to separate aggregated protein and the 
supernatant containing active protein was buffer exchanged into storage buffer (50 mM 
HEPES, 300 mM KCl, 10 mM DTT and 10% v/v glycerol) using PD-10 columns (GE Life 
Sciences). The protein solution was then concentrated using pall 30 kDa spin columns, 
divided into 50µl aliquots, flash frozen and stored at −80℃. 
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Determining the concentration of MftC: 
 
The final concentration of MftC in solution was determined by recording 
absorbance at 280 nm, using a molar extinction Coefficient of 39420 M−1∙cm−1(assuming 
cysteines are reduced). The molar extinction coefficient for MftC was computed using the 
ExPASy ProtParam web tool [1]. All the absorbance measurements were carried out in a 
Shimadzu UV – 1800 UV-visible spectrophotometer.  
 
Iron sulfur quantification of MftC: 
 
The quantification of iron and sulfur content of reconstituted protein was conducted 
according to the procedure previously reported [66]. After determining the concentration 
of the protein through Bradford assay, 100 µl of 20 µM protein was mixed with 10 µl of 
3M TCA and the protein precipitate was centrifuged at 15,000g for 10 mins and the 
supernatant is removed and diluted with 330 µl of diH2O. A volume of 20 μl of 10mM  
sodium ascorbate, 20 μL of 10 mM ferrozine, and 20 μl of saturated sodium acetate (room 
temperature) were added to the solution and the absorbance change due to the 
ferrozine−iron complex was measured at 562 nm (ε = 27.9 mM−1 cm−1 ). 
The sulfur concentration was measured through mixing 200 µl of 10 µM was added 
to 600 μL of 1% (w/v) zinc acetate and 50 μL of 7% (w/v) sodium hydroxide. The solution 
was allowed to rest at room temperature and 150 μL of 0.1% (w/v) N, N-dimethyl-p-
phenylenediamine (in 5 M HCl) and 150 μL of 10 mM FeCl3 (in 1 M HCl) were added. 
The solution was vortexed and incubated at room temperature for 20 min. The absorbance 
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from methylene blue was measured at 670 nm.  Blanks were made for both measurements 
using diH2O instead of protein.  
 
Expression and Purification of GST-His MftB: 
 
A previously constructed pGEX6p-1 plasmid construct containing the mftB gene 
(Uniprot: A0PM48) out of which the first 20 amino acids were truncated to reflect the 
updated Uniprot annotation was fused with GST (Glutathione-S-Transferase) with an C-
terminal His tag was transformed into T7 Express lysY/Iq competent cell line and was 
allowed to grow overnight on agar plates with appropriate antibiotic selection. An 
overnight starter culture from the plate grown at 37℃ was used to inoculate 4L of LB 
medium and incubated at 37℃ and 215 RPM till the culture reached an OD600 measurement 
of 0.6 to 0.8. The culture was cooled to 21℃ and induced by adding 1mM IPTG (Isopropyl 
β- D -1-thiogalactopyranoside) and incubated overnight for a period of 16 to 18 hr at 215 
RPM at 21℃. The cells were then centrifuged at 6500 g for 10 min to spin down the cells 
in the growth medium. The cells were then aliquoted, flash frozen and stored in the −80℃. 
 
The purification of mftB was conducted inside the anaerobic chamber. The cells 
were thawed inside the anaerobic chamber and resuspended in 5-fold cell pellet volume of 
lysis buffer (50 mM HEPES, 300 mM NaCl, 40 mM Imidazole). Lysozyme (0.5% w/v) 
and DNAse (Bovine Pancreas, 0.05 mg/g of thawed cells) were added and the solution was 
stirred at room temperature for 20 min. The cells suspension was then sonicated and 
centrifuged at 13000g for 10 mins and loaded onto two 5 ml Ni2+ NTA His columns (GE 
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Life Sciences). The columns were then washed with 5 column volumes of lysis buffer (50 
mM HEPES, 300 mM NaCl, 40 mM Imidazole) and then with the elution buffer (50 mM 
HEPES, 300 mM NaCl and 300 mM Imidazole). The UV absorbance of the eluant was 
monitored and appropriate fractions were collected and pooled. The eluted protein samples 
were buffer exchanged into a storage buffer (50 mM HEPES, 250 mM KCl, 1 mM TCEP 
and 10% v/v Glycerol) using PD-10 columns (GE Life Sciences). The final protein solution 
was concentrated using pall 30 kDa columns and aliquoted into 50 µL aliquots, flash frozen 
and stored at −80℃. 
 
 
Iron-sulfur Cluster degradation assay: 
 
An initial absorption spectra reading was taken from 220 nm to 500 nm for 50 µM 
of purified and reconstituted MftC in anaerobic storage buffer without a reference spectrum 
reading. Then an aerobic storage buffer without any reductant was prepared (50 mM 
HEPES, 300 mM KCl and 10% v/v Glycerol). Approximately 10 µL of 2.5 mM MftC was 
diluted into 490 µL of aforementioned oxygenated buffer mixed thoroughly and brought 
up to a final concentration of 50 µM in a quartz cuvette which was then sealed in an airtight 
manner. Absorption spectra readings from 220 nm to 500 nm were taken every 30 minutes 
for 24 hours. This experiment was performed in triplicate and change in 410 nm absorbance 





Time course reactions for uncoupled (without co-substrate MftA and MftB) SAM 
cleavage reaction with wildtype MftC (anaerobic MftC): 
 
All reactions were conducted in the anaerobic chamber. All the reagents were 
prepared as described above. The reactants were mixed in the following order: anaerobic 
reaction buffer (50 mM HEPES, 300 mM KCl and 10% v/v glycerol), 10 mM DTT, 1.1 
mM SAM, 100 µM MftC and 4 mM DTH. The time course reactions were conducted over 
24 h at room temperature. The formation of 5’deoxyadenosine was measured at designated 
time intervals.  
 
Time course reactions for uncoupled oxygenated SAM cleavage reaction with 
oxygenated MftC: 
 
All reactions were conducted in the anaerobic chamber. Purified and reconstituted 
MftC was buffer exchanged into and an oxygenated buffer (50 mM HEPES, 300 mM KCl 
and 10% v/v glycerol) and incubated at 4℃ for 0.5, 6, and 12 h in separate aliquots. 
Uncoupled SAM cleavage reactions were set up with each of the different oxygenated 
samples after buffer exchanging them back in anaerobic buffer (50 mM HEPES, 300 mM 
KCl and 10% v/v glycerol) containing reductant (DTT) to stop further decay of the iron 
sulfur clusters[148]. The reactions were set up in the same manner as described in the 
previous experiment and the same time course experiment was performed for all of the 
oxygenated varieties in triplicate and formation of 5’deoxyadenosine was monitored using 




MftA modification reaction with anaerobic MftC: 
 
A truncated version of MftA (12-30) was bought in synthesized form from 
GenScript Biotech Corporation and was used in further experiments. All reactions were 
carried out in the anaerobic chamber and the reactants were added as follows: the reaction 
buffer (50 mM HEPES, 300 mM KCl and 10% v/v glycerol), 10mM DTT, 200 µM MftA, 
205 µM MftB, 800 µM SAM, 350 µM MftC and 4 mM DTH. A time course reaction was 
set up and aliquots were taken at specific intervals to facilitate measurement of initial rates 
of formation of MftA**, MftA*, and the decrease of MftA. These were measured through 
reverse phase HPLC.  
 
MftA modification reactions with oxygenated species of MftC: 
 
All experiments were set up inside the chamber as above with the same synthesized 
version of (12-30) MftA. MftC used in this reaction was buffer exchanged into oxygenated 
buffer (50 mM HEPES, 300 mM KCl and 10% v/v glycerol) and allowed to incubate 3, 6 
and 12 h at 4℃ before being buffer exchanged in anaerobic buffer (50 mM HEPES, 300 
mM KCl and 10% v/v glycerol)  with DTT as stated in the previous experiments to prevent 
further oxygen decay. The reactants were added as follows: the reaction buffer (50 mM 
HEPES, 300 mM KCl and 10% v/v glycerol), 10mM DTT, 200 µM MftA, 205 µM MftB, 
800 µM SAM, 350 µM MftC and 4mM DTH. Time course reactions were conducted with 
each of the oxygenated species and initial rates of formation of MftA**, MftA* and the 






CHAPTER THREE: RESULTS 
 
Deterioration of [4Fe-4S] clusters of MftC 
 
It was theorized that since MftC has three iron sulfur clusters (one SAM and two 
auxiliary clusters) oxidative degradation of MftC would proceed in distinct stages with 
degradation of one cluster at a time. To test this, the decline in absorbance at 410 nm was 
measured over 24 h. Specifically, [4Fe-4S] clusters show absorbance specifically at 410 
nm and the attenuation of the absorbance shoulder at 410 was taken as a sign of cluster 
degradation. It was seen that rather than a step wise degradation or distinct stages of the 
410 nm absorbance attenuation, the absorbance signal decreased in a steady manner over 
24 hours (Figure 25).  
                        
Figure 25. Attenuation of 410nm absorbance over 24 hours of MftC 
in oxygenated buffer. Absorption spectrum reading taken at every 30 
minutes for 24 hours and normalized absorption readings at 410 nm 
(mAu) plotted against time in hours.  
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Since distinct phases of degradation in the 410 nm absorbance were not observed, 
it could be that there is no specific order for the degradation of the three clusters and the 
overall attenuation of the 410 nm absorbance signal is the result of aggregate of populations 
of MftC undergoing degradation of different clusters simultaneously. The rate of 
degradation was found to be 0.2 ± 1×10-2 min-1 after fitting the data on to a one-phase-
decay model. It was expected that the rSAM cluster and the Aux I clusters undergo 
degradation faster than Aux II cluster as it might be nestled in the middle of the protein 
sequence and therefore shielded better from molecular oxygen in the solution compared to 
the other two clusters.  Even if multiple phases of degradation are considered, the distinct 
phases cannot be gleaned from the present data as the data reflects the average degradation 
of different populations and phases of degradations. 
 
 
Uncoupled and full reactions of both anaerobic MftC and oxygenated MftC. 
 
Biosynthesis of mycofactocin was shown to be crucial for the persistence of 
infection by M. tuberculosis while present in the alveolar tissue. In addition, the pathway 
was shown to be crucial for cholesterol utilization as an energy source which is a crucial 
energy source while enveloped by macrophages [149]. The alveolar tissue is a very oxygen 
rich (concentration) environment however the first step in the mycofactocin biosynthesis 
is the post-translational modification of the precursor peptide MftA in the mycofactocin 
pathway by the rSAM enzyme MftC.  
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It was expected that even though MftC was an rSAM enzyme, which are typically 
oxygen sensitive, the enzyme would have to be at least partially tolerant of oxygen to 
function in an oxygen rich environment such as the alveolar tissue, which might introduce 
oxygen rich species into the cell cytosol even if the cytosol in general is reducing in nature 
[150]. Hence the rate of reactions catalyzed by MftC in various states of oxidative cluster 
degradation were tested. The purified, reconstituted protein was buffer exchanged into 
oxygenated buffer incubated for specific intervals of time before being buffer exchanged 
back into anaerobic buffer to initiate uncoupled (without MftA and MftB) and coupled 











Uncoupled SAM cleavage reactions were performed in triplicate inside the 
anaerobic chamber with anaerobic MftC, MftC incubated in oxygenated buffer for 0.5, 6, 
and 12 h. The time course experiments showed a highly unusual result where the reaction 
Figure 26. Uncoupled SAM cleavage reactions. 5’deoxyadenosine (5’dAdo•) 
radical formation plotted against time. (A) Fully Anaerobic MftC cleavage of 
SAM. (B) SAM cleavage by MftC incubated in aerobic buffer for 0.5 hours. (C)  
SAM cleavage by MftC incubated in aerobic buffer for 6 hours. (D)   SAM 
cleavage by MftC incubated in aerobic buffer for 12 hours. 
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rate was sped up with exposure to oxygen. The pseudo-first-order rate constant for the 
SAM cleavage reaction with fully anaerobic MftC (Figure 26 A) was  4.32 ± 1.08 min-1 , 
whereas the pseudo-first-order rate constants for 0.5, 6, and 12 h aerobic buffer incubated 
MftC SAM cleavage reactions (Figure 26 B-D) were 30.72 ± 4.98 min-1, 13.2  ± 0.9 min-1 
and 14.94 ± 2.28 min-1 respectively. A number of explanations can be postulated for this 
result and the most prominent among them are structural changes due to degradation of the 
Aux I and the Aux II clusters which might cause conditions mimicking a coupled reaction 
 
                  
 
In the anaerobic coupled reaction (Figure 27) the conversion of MftA has a fast and 
a slow process. The fast decay step corresponds with the sharp increase in MftA** 
accumulation in the beginning of the reaction. The slow steps of the decay of MftA** and 
the final accumulation of MftA* occur in the same timeframe indicating that the C–C bond 
formation – the latter, seemingly slower step might be the rate limiting step of the whole 
peptide modification reaction. The first five data points were taken within a minute of 
initiation of reaction and the fast decay step happens within the first ten seconds of reaction 
Figure 27. Coupled anaerobic MftC reaction. (A) exponential decay of MftA fitted to 
a two-phase disassociation model which shows a  fast phase and a slow phase over a 
period of 60 minutes. (B) The panel shows the disassociation of MftA** over 60 
minutes and (C) shows the formation of MftA*. 
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initiation. As a result, even with a two-phase-decay model used for fitting the data which 
allows the inclusion of a fast step and a subsequent slow step, there were not enough initial 
data points to assign a very accurate upper limit for the confidence interval for the fast step 
and as a result, the rate constant for the fast step produced by the fitting kfast = 13.33  min
-
1 has to be taken with relative caution. 
The fit was however able to obtain a relatively accurate rate constant for the slow 
step of the decay and it was calculated to Kslow = 0.105 ± 6 × 10
-2 min-1. The rate of 
formation of MftA** was within the ten seconds of the reaction initiation and hence only 
the rate of decay of the MftA** was calculated by fitting the data to a one-phase-decay 
model. The rate constant of the MftA** was calculated to be  0.068 ± 0.013 min-1. The data 
for the rate of formation of MftA* was fitted on to a two-phase-association model and the 
rate of formation of MftA*, k = 0.074 ± 0.02 min-1 was found to be comparable to the rate 
of MftA** decay. This is consistent with the proposed mechanism of reaction where the 
precursor peptide gets converted into MftA** after the oxidative decarboxylation step and 
then into MftA* where a C – C bond is conferred on the C-terminal of the peptide.  
        
. 
Figure 28. Coupled peptide modification reaction with MftC exposed to oxygen for 3 
hours. (A) Decrease in concentration of MftA w.r.t time fitted on to a two-phase-
exponential-decay model. (B) Increase and decrease in concentration of MftA** w.r.t 




The coupled reaction was seen to have lowered reaction rates when MftC was 
exposed to oxygen. Figure 28 shows reactions involving MftC that had been incubated in 
oxygenated buffer for three hours before being used in a coupled reaction. Panel A in the 
figure shows the decrease in concentration of MftA with time and again a two-phase-decay 
model was used to fit the data through which an accurate rate for the slow step was 
calculated - Kslow = 0.122 ± 7 × 10
-2  min-1. The rate of formation and decay of MftA** 
could not be properly plotted as the absorbance data became inconsistent for MftA** when 
oxygenated MftC was used in the reactions, however the rate constant for the formation of 
MftA* could calculated with the data being fitted on to a one-phase-association model. The 
rate constant for the formation of MftA* was found to be k = 0.063 ± 0.015 min-1. It was 
noted that the rate constant for the formation of MftA* in this experiment with the 
oxygenated buffer was comparable to the rate constant of MftA* formation in the previous 
reaction with completely anaerobic MftC.  




Figure 29. Coupled peptide modification reaction with MftC exposed to oxygen for 6 
hours. (A) Decrease in concentration of MftA w.r.t time fitted on to a two-phase-
exponential-decay model. (B) Increase and decrease in concentration of MftA** w.r.t 




The results of the coupled peptide modifying reaction with MftC that was oxidized 
longer is consistent with the predicted trend of slowing down of reactions with increasing 
oxidative degeneration of MftC. The above figure (Figure 29) shows the results of a 
coupled reaction set up with MftC that had been incubated in oxygenated buffer for 6 hours. 
The rate of decrease in the concentration of MftA when fitted to two-phase-decay model 
was found to be 0.088 ± 0.02 min-1 which is slower than the rate of decay in the experiment 
with MftC incubated in oxygenated buffer for 3 hours (Figure 28). The rate of formation 
and decay of MftA** could not be calculated for the same reasons as mentioned in the 
previous experiment. The rate of MftA* formation however was calculated when the data 
was fitted to a one-phase-association model and it was found to be 0.061 ± 0.02 min-1. 
It is to be noted that the rate of formation of MftA* for all three reactions with anaerobic 
MftC and with MftC incubated in oxygenated buffer for 3 hours and 6 hours was very 
comparable and nearly the same.  
This points to possibility that the rate of C – C bond formation reaction instituted 
by the MftC on MftA** to modify it into MftA* is not affected by the oxidation of MftC 
whereas the conversion of MftA into MftA** is affected by oxidation. An inverse 
relationship is seen with the decrease in the rate of decay of MftA with increasing oxidative 











CHAPTER FOUR: DISCUSSION AND SUMMARY  
 
MftC is a rSAM enzyme in the mycofactocin biosynthesis pathway and is 
responsible for post-translationally modifying the precursor peptide MftA as the first step 
in the Mycofactocin biosynthesis[138]. MftC also has been confirmed to have three [4Fe-
4S] clusters out of which the rSAM cluster is shown to be essential for the reductive, 
homolytic cleavage of SAM and the additional two clusters Aux I and Aux II clusters are 
shown to be involved in peptide modification while not being essential for SAM 
cleavage[136]. MftC also belongs in the SPASM subfamily of proteins of which it is a 
founding member[151]. MftC catalyzes the formation of a C – C bond between Cα carbon 
of the N terminal tyrosine and Cβ of the penultimate valine in the C terminus of the 
precursor peptide. MftC utilizes two equivalents of SAM to complete the oxidative 
decarboxylation of the tyrosine followed by the C – C bond formation both of which are 
SAM dependent. MftC by the nature of its oxygen sensitivity is thought to only catalyze 








            
The [4Fe-4S] clusters show absorbance at 410 nm and incubation of purified and 
reconstituted MftC in oxygenated buffer has shown to result in attenuation of 410 nm 
absorbance which is indicative of degradation of the [4Fe-4S]2+ clusters. There were no 
distinct phases or segments and the deterioration of the signal was relatively uniform and 
the rate of signal decay was found to be 0.20 ± 0.06 × 10-2  min-1. 
The effect of oxidation of MftC was tested on rate of uncoupled SAM cleavage 
reactions and the rate of 5’dA radical formation was counterintuitively found to be 
enhanced after exposure to oxygen. The rate of 5’dA production with completely anaerobic 
conditions was 4.32 ± 1.08 min-1 whereas the 5’dA production rate was increased several 
orders of magnitude to 30.72 ± 4.98 min-1, 13.2  ± 0.9 min-1 and 14.94 ± 2.28 min-1 for the 
0.5 hour, 6 hours and 12 hours oxygen exposed MftC respectively. The rate seems to have 
decreased after prolonged oxidation as seen in the case of the 6- and 12-hour oxygen 
incubated samples after the initial increase (0.5 hr of oxygen incubation). Since the enzyme 
still continues to function even after 12 hours of oxygen exposure, it is highly likely that 
Figure 30. Major steps of the MftC reaction where MftA is converted into MftA* 
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the r-SAM cluster or the Adomet cluster is solvent protected and does not have extensive 
contact with the solvent for it to be degraded even after extensive time periods of oxygen 
exposure. There are many factors which influence the reaction rate and initiation of the 
SAM cleavage reaction itself, the presence of substrate is shown to increase SAM cleavage 
rate in general in rSAM enzymes[143]. If the attenuation of the 410 nm signal is assumed 
to be from the auxiliary clusters, then the degradation of the auxiliary clusters might cause 
structural rearrangement or change in the structure of the protein back bone which might 
emulate the same condition as the binding of the substrate, thus increasing the rate of SAM 
cleavage which can only be confirmed through further structural and biochemical 
characterization of MftC in oxidized state.  
Another reason for the observed increase in rate might be due to changes in polarity 
of the active site environment [153]. The degradation of the auxiliary clusters could lead 
to structural changes in the protein which if decrease the polarity of the Adomet cluster 
active site, the rate of SAM cleavage reactions can significantly go up. An alteration in the 
redox potentials at the site of the Adomet cluster [154] due changed secondary structure 
elements and can also lead to increased reaction rate.  
The reaction rate of coupled reaction seems to be affected in more intuitive manner 
following oxidation of MftC. The rate of decay of MftA is decreased with the increase in 
oxidation of MftC whereas the rate of formation of MftA* remains relatively the same 
(0.074 ± 0.02 min-1 for anaerobic MftC, 0.063 ± 0.015 min-1 for MftC incubated in oxygen 
for 3 hours and 0.061 ± 0.02 min-1 for MftC that was incubated in oxygenated buffer for 6 
hours)  in all the peptide modification experiments. This shows that the second part of the 
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MftC reaction, the C – C bond formation between the C terminal tyrosine and the 
penultimate valine might not be oxygen sensitive even though SAM is consumed for the 
reaction to happen. This can also alternatively indicate that the step is not dependent on the 
auxiliary clusters even if it is SAM dependent [136]. 
    M. tuberculosis  invades the human body primarily though inhaled droplets that 
deposit in the alveolar tissue [155]. Alveoli are highly oxygenated environs within the body 
[156] and is populated by macrophages which ingest most of the M. tuberculosis cells  and 
form the primary line of defense against the pathogen [157]. M. tuberculosis has to sustain 
metabolic functions before forming granulomas which can produce partial anoxic 
conditions at the core of the granuloma [158]. This leads again to the question of how the 
pathogenic bacterium manages to produce mycofactocin which is required for metabolic 
activity while inside the macrophage [87] since one of the steps involves MftC which only 
works optimally in an anaerobic environment [159]. The results indicate a certain level of 
oxygen tolerance exhibited by MftC which could explain how the M. tuberculosis species 
successfully invades and thrives in a very oxygen rich environment while requiring an 
anaerobic step to produce the redox cofactor which in turn is required for metabolic 
activity. It is also plausible that this oxygen tolerance could be enhanced in vivo as the 
protein is in its native environment.  
Further biochemical and structural characterization of MftC is required to fully 
investigate the role of auxiliary clusters and their oxidative degradation in the peptide 




One of the ways to isolate the effect of oxygen degradation on the SAM cleavage 
reaction is to express and purify a truncated version of MftC which has only the parital 
TIM barrel part of the enzyme which hosts the SAM cluster. Experiments with UV 
absorbance measurements on the continuous oxygen degradation and SAM cleavage 
reactions with the partial enzyme would isolate the oxygenation effect to just the SAM 
cluster. This can open up possibilities of investigation on why there was an observed 
increase in the rate of SAM cleavage on slight oxidation of the protein. Another possible 
avenue of investigation would be deletion of the conserved residues hosting the auxiliary 
clusters and performing oxidative degeneration experiments on mutationally altered 
versions of MftC which do not host the Auxiliary clusters to test the effect on the SAM 
cleavage reaction. 
Hydrogen–deuterium exchange experiments can be performed on MftC to 
determine areas of the protein that are more solvent accessible than other regions. This can 
potentially point out the clusters that are more solvent accessible. This can lead to more 
information on how cluster degradation proceeds on dissolved oxygen exposure through 
the solvent. 
Exploring these avenues might shed light into another dimension of virulence 
exhibited by M. tuberculosis and also can lead  to much better understanding of rSAM 
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